A Prospective Observational Study of Antihemophilic Factor (Recombinant) Prophylaxis Related to Physical Activity Levels in Patients with Hemophilia A in the United States (SPACE)

Barbara A Konkle1 Department of Medicine, The University of Washington and Bloodworks Northwest, Seattle, WA, USA

Doris V Quon2 Orthopaedic Hemophilia Treatment Center, Orthopaedic Institute for Children, Los Angeles, CA, USA

Leslie Raffini3 Division of Hematology, Children’s Hospital of Philadelphia, Philadelphia, PA, USA

Michael Recht4 The Hemophilia Center, Oregon Health & Science University, Portland, OR, USA

Vlad C Radulescu5 Department of Pediatric Hematology and Oncology, University of Kentucky Medical Center, Lexington, KY, USA

Shannon L Carpenter6 Department of Hematology/Oncology, Children’s Mercy Hospital, Kansas City, MO, USA

Amy L Dunn7 Hemophilia Treatment Center, Nationwide Children’s Hospital and The Ohio State University College of Medicine, Columbus, OH, USA

Mei Lu8 Takeda Development Center Americas, Inc, Lexington, MA, USA

Maureen Watt9 Outcomes Research & Epidemiology, Takeda Pharmaceuticals International AG, Zurich, SwitzerlandCorrespondence[email protected]

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.